Patient willingness to undergo chemotherapy and thoracic radiotherapy for locally advanced non-small cell lung cancer

Psycho-Oncology

Volumn 18, Issue 5, 2009, Pages 483-489

  Hirose, Takashi ^a   Yamaoka, Toshimitsu ^a   Ohnishi, Tsukasa ^a   Sugiyama, Tomohide ^a   Kusumoto, Sojiro ^a   Shirai, Takao ^a   Okuda, Kentaro ^a   Ohmon, Tohru ^a   Adachi, Mitsuru ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapy; Non small cell lung cancer; Oncology; Patient willingness; Thoracic radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANOREXIA; ARTICLE; BLEEDING; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG FEVER; DRUG TOLERABILITY; FATIGUE; FEMALE; HUMAN; INFECTION; JAPANESE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; PATIENT ATTITUDE; QUESTIONNAIRE; STOMATITIS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ATTITUDE TO HEALTH; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFORMED CONSENT; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; QUESTIONNAIRES; RADIOGRAPHY, THORACIC; RADIOTHERAPY DOSAGE;

EID: 67949085166     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1450     Document Type: Article

References (25)

1. Perez CA, Stanley K, Grundy G et al. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Cancer 1982;50:1091-1099.
2. Pritchard RS, Anthony SP. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. Ann Intern Med 1996;125: 723-729.
3. Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br Med J 1995; 311:899-909.
4. Pfister DG, Johnson DH, Azzoli CG et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 2004;22:330-353.
5. Brundage MD, Feldman-Stewart D, Cosby R et al. Phase I study of a decision aid for patients with locally advanced non-small-cell lung cancer. J Clin Oncol 2001;19:1326-1335.
6. Slevin ML, Stubbs L, Plant HJ et al. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. Br Med J 1990;300:1458-1460.
7. Brundage MD, Davidson JR, Mackillop WJ. Trading treatment toxicity for survival in locally advanced non-small cell lung cancer. J Clin Oncol 1997;15:330-340.
8. Silvestri G, Pritchard R, Welch HG. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. Br Med J 1998;317:771-775.
9. Bremnes RM, Andersen K, Wist EA. Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy. Eur J Cancer 1995;31A: 1955-1959.
10. Lee AWM. Radiation therapy in Hong Kong: heritage and current status. Int J Radiat Oncol Biol Phys 1997; 37:131-136.
11. Blackhall LJ, Murphy ST, Frank G, Michel V, Azen S. Ethnicity and attitudes toward patient autonomy. J Am Med Assoc 1995; 274:820-825.
12. Ruhnke GW, Wilson SR, Akamatsu T et al. Ethical decision making and patient autonomy: a comparison of physicians and patients in Japan and the United States. Chest 2000;118:1172-1182.
13. Ngo-Metzger Q, McCarthy EP, Burns RB, Davis RB, Li FP, Phillips RS. Older Asian Americans and Pacific Islanders dying of cancer use hospice less frequently than older white patients. Am J Med 2003; 115:47-53.
14. Dillman RO, Herndon J, Seagren SL, Eaton Jr WL, Green MR. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of Cancer and Leukemia Group B (CALGB) trial. J Natl Cancer Inst 1996;88:1210-1215.
15. Sause WT, Scott C, Taylor S et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced unresectable non-small-cell lung cancer. J Natl Cancer Inst 1995; 87:198-205.
16. Curren WJ, Scott CB, Langer CL et al. Long-term benefit is observed in a phase III comparison of sequential vs. concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410. Proc Am Soc Clin Oncol 2003;22:621.
17. Furuse K, Fukuoka M, Kawahara M et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 1999;17:2692-2699.
18. Ohe Y, Ishizuka N, Tamura T et al. Long-term follow-up of patients with unresectable locally advanced non-small cell lung cancer treated with chemoradiotherapy: a retrospective analysis of the data from the Japan Clinical Oncology Group trials (JCOG0003A). Cancer Sci 2003;94:729-734.
19. Nilchaikovit T, Hill JM, Holland JC. The effects of culture on illness behavior and medical care: Asian and American differences. Gen Hosp Psychiatry 1993;15: 41-50.
20. Schroen AT, Detterbeck FC, Crawford R, Rivera MP, Socinski MA. Beliefs among pulmonologists and thoracic surgeons in the therapeutic approach to non-small cell lung cancer. Chest 2000;118: 129-137.
21. Raby B, Pater J, Mackillop WJ. Does knowledge guide practice? Another look at the management of non-small-cell lung cancer. J Clin Oncol 1995;13: 1904-1911.
22. Palmer MJ, O'Sullivan B, Steele R, Mackillop WJ. Controversies in the management of non-small cell lung cancer: the results of an expert surrogate study. Radiother Oncol 1990;19:17-28.
23. Earle CC, Neumann PJ, Gelber RD, Weinstein MC, Weeks JC. Impact of referral patterns on the use of chemotherapy for lung cancer. J Clin Oncol 2002; 20:1786-1792.
24. Yellen SB, Cella DF, Leslie WT. Age and clinical decision making in oncology patients. J Natl Cancer Inst 1994;86:1766-1770.
25. Newcomb PA, Carbone PP. Cancer treatment and age: patient perspective. J Natl Cancer Inst 1993;85:1580-1584.